Mono Pharmacare Limited (NSE: MONOPHARMA) is an Ahmedabad, Gujarat-based company in the Pharmaceutical Product Distribution industry. With a market capitalisation of ₹18 Cr, it ranks #4,494 by market cap among the 6,197 Indian listed companies on FinBizNet, and #10 of 13 in Pharmaceutical Product Distribution. At ₹10.25 (as of 16 Nov 2026), the share price is 53.5% below its 52-week high of ₹22.05 and 36.7% above its 52-week low of ₹7.50. The share price is down 50.0% over one year and up 30.6% over three months.
| Current Price | ₹10.25 |
|---|---|
| Market Cap | ₹18 Cr |
| NSE Symbol | MONOPHARMA |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Distributors > Pharmaceutical Product Distribution |
| P/E Ratio | 25 |
| Return on Equity | 1.12% |
| Return on Assets | 2.37% |
| 52-Week Range | ₹7.50 – ₹22.05 |
| 1-Year Price Change | -50.0% |
| 3-Month Price Change | +30.6% |
| Beta (1Y) | 0.4 |
| Headquarters | Ahmedabad, Gujarat |
| Website | monopharmacareltd.com |
Mono Pharmacare Limited engages in the distribution of pharmaceutical items in India. The company markets healthcare products, such as antibiotics, cough cold anti allergics, antifungal, nutraceutical, analgesic and antipyretic, antacid and antiemetic, cardiac diabetic, skincare, antiseptic, bronchodilators, probiotics, and antihistamines. It also offers products under the Cosmo Care brand; eye and ear drops, nasal spray, gynec, herbal, and skincare products. The company was founded in 1964 and is based in Ahmedabad, India.
1. NA-NA 2. NA-NA 3. NA-NA 4. NA-NA
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Entero Healthcare Solutions Limited | ₹8,733 Cr | 74.6 | 8.28% | ₹2,087 Cr | +80.7% |
| Remus Pharmaceuticals Limited | ₹941 Cr | 26.1 | 13.78% | — | +0.6% |
| Health X Platform Limited (Sastasundar Ventures Ltd) | ₹871 Cr | 752.7 | -0.18% | ₹484 Cr | -5.7% |
| Aptus Pharma Limited | ₹837 Cr | 156.8 | — | — | +754.0% |
| Vasa Denticity Limited | ₹797 Cr | 76.5 | 6.68% | ₹87 Cr | -21.4% |
| Bijoy Hans Ltd | ₹523 Cr | — | — | — | +128.4% |
| Speciality Medicines Limited | ₹149 Cr | 11.5 | — | — | — |
| Vijaypd Ceutical Limited | ₹136 Cr | 23 | 9.53% | — | — |
| Mono Pharmacare Limited | ₹18 Cr | 25 | 1.12% | — | -50.0% |
Listed by market capitalisation. Ratios are shown for context only.
Mono Pharmacare Limited is trading at ₹10.25, with a market capitalisation of ₹18 Cr.
Mono Pharmacare Limited operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Distributors > Pharmaceutical Product Distribution).
Mono Pharmacare Limited has a P/E of 25 and a return on equity of 1.12%.
Mono Pharmacare Limited is listed on the NSE under the symbol MONOPHARMA.
Mono Pharmacare Limited's share price is down 50.0% over one year and up 30.6% over three months. Its 52-week range is ₹7.50 to ₹22.05.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.